Advances in Lung Cancer Treatment

Keith D. Eaton, MD, PhD reflects on the past 15 years of his career and discusses advancements in lung cancer treatment. He focuses on metastatic Non-Small Cell Lung Cancer (NSCLC) and the outcomes of targeted therapies.